Pancytopenia in a Patient with Rendu-Osler-Weber Syndrome and Uncommon Vascular Abnormalities

by Nicolò Binello, Antonio Gasbarrini, Eleonora Gaetani
Published 2016-01-01

Prevention and treatment of Clostridium difficile infection

by Gianenrico Rizzatti, Gianluca Ianiro, Giovanni Cammarota, Antonio Gasbarrini
Published 2017-12-01

VIRAL CIRRHOSIS: AN OVERVIEW OF HAEMOSTATIC ALTERATIONS AND CLINICAL CONSEQUENCES

by Antonio Gasbarrini, Valerio De Stefano, Francesca Romana Ponziani
Published 2009-11-01

Diet and Nutrients in Gastrointestinal Chronic Diseases

by Antonio Corsello, Daniela Pugliese, Antonio Gasbarrini, Alessandro Armuzzi
Published 2020-09-01

VIRAL CIRRHOSIS: AN OVERVIEW OF HAEMOSTATIC ALTERATIONS AND CLINICAL CONSEQUENCES

by Francesca Romana Ponziani, Valerio De Stefano, Antonio Gasbarrini
Published 2009-12-01

Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma

by Francesca Romana Ponziani, Alberto Nicoletti, Antonio Gasbarrini, Maurizio Pompili
Published 2019-05-01

Irritable Bowel Syndrome (IBS) and Non-Celiac Gluten Sensitivity (NCGS): Where Is the Culprit Hiding? Nutritional Tips for Gastroenterologists

by Emanuele Rinninella, Marco Cintoni, Maria Cristina Mele, Antonio Gasbarrini
Published 2019-10-01

Stem Cell-Based Therapies for Liver Diseases: State of the Art and New Perspectives

by Anna Chiara Piscaglia, Mariachiara Campanale, Antonio Gasbarrini, Giovanni Gasbarrini
Published 2010-01-01

THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE

by Lucrezia Laterza, Gianenrico Rizzatti, Eleonora Gaetani, Patrizia Chiusolo, Antonio Gasbarrini
Published 2016-05-01

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy

by Francesca Fianchi, Antonio Liguori, Antonio Gasbarrini, Antonio Grieco, Luca Miele
Published 2021-06-01

Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track

by Emanuele Rinninella, Marco Cintoni, Pauline Raoul, Antonio Gasbarrini, Maria Cristina Mele
Published 2020-11-01

Title not available

by Andrea Marcellusi, Luca Bianchi, Antonio Gasbarrini, Guido Valesini, Francesco Saverio Mennini
Published 2017-07-01

Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase

by Alfredo Papa, Valerio Papa, Loris Riccardo Lopetuso, Antonio Gasbarrini, Antonio Tursi
Published 2020-10-01

Economic impact of biosimilar drugs in Italy: past, present and future of infliximab and etanercept

by Andrea Marcellusi, Luca Bianchi, Antonio Gasbarrini, Guido Valesini, Francesco Saverio Mennini
Published 2017-07-01

Gut Microbiota: Modulate its Complexity to Restore the Balance

by Fermín Mearin, Speakers Fermín Mearin, Antonio Gasbarrini, Peter Malfertheiner, Mark Pimentel
Published 2015-12-01

Tumor Initiating Cells and Chemoresistance: Which Is the Best Strategy to Target Colon Cancer Stem Cells?

by Emanuela Paldino, Valentina Tesori, Patrizia Casalbore, Antonio Gasbarrini, Maria Ausiliatrice Puglisi
Published 2014-01-01

Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis

by Maria Cerreto, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani
Published 2021-07-01

The Role of Nutrition in the COVID-19 Pandemic

by Maria Chiara Mentella, Franco Scaldaferri, Antonio Gasbarrini, Giacinto Abele Donato Miggiano
Published 2021-03-01

Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery

by Alfredo Papa, Antonio Tursi, Silvio Danese, Gianludovico Rapaccini, Antonio Gasbarrini, Valerio Papa
Published 2020-07-01

A new decision model for economic evaluation of novel therapies for HCV

by Matteo Ruggeri, Americo Cicchetti, Silvia Coretti, Carlo Cammà, Nicola Caporaso, Antonio Gasbarrini
Published 2014-09-01